Northwest Biotherapeutics reported 27.52M in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agenus AGEN:US $ 456.17M 14.87M
Applied Genetic Technologies AGTC:US $ 66.68M 20.51M
AstraZeneca AZN:LN 7932612.74M 297425.43M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Celldex Therapeutics CLDX:US $ 402.96M 21.08M
Cti Biopharma CTIC:US $ 134.53M 3.1M
Cytori Therapeutics CYTX:US $ 21.27M 3.24M
Cytrx CYTR:US 6.56M 2.16M
Eisai 4523:JP Y 1272871M 33556M
Genocea Biosciences GNCA:US $ 38.79M 17.18M
Infinity Pharmaceuticals INFI:US $ 61.86M 10.72M
Mirati Therapeutics MRTX:US $ 1279.79M 141.51M
Northwest Biotherapeutics NWBO:US 27.52M 3.14M